Although the specific mechanism of immune checkpoint blockades are not fully understood, some studies suggested that the PI3K pathway is involved in PD-L1 expression and immunoresistance in tumor cells [12, 34, 35]. This evidence concerns the gene PIK3CD and neoplasm.